Abstract
Background and Goals: The current study investigated the relationship between gang involvement and multiple mental health difficulties; anxiety, depression, paranoia, victim trauma and perpetrator trauma. Additionally, it examined the mediating influence of an individual’s exposure to violence within this relationship.
Method: One hundred adolescents aged 11-16 years old completed two questionnaires and an interview which investigated their friendship groups, exposure to violence and mental well-being. Eighteen participants were identified as current or ex-gang members and the other eighty-two were classified as the nongang comparison group. Results: Findings show that gang members displayed more symptoms of depression and perpetrator trauma compared to non-gang members. The relationship between gang involvement and these mental health difficulties was mediated by exposure to violence. Conclusion: Discussion focuses on the need for researchers, practitioners and policymakers to acknowledge the relationship between gang involvement and mental health difficulties and implement additional strategies to support young people currently or previously involved in gangs.Keywords: Gangs, anxiety, depression, paranoia, victim and perpetrator trauma, mental-illness.
Adolescent Psychiatry
Title:Gang Involvement, Mental Health Difficulties and Exposure to Violence in 11-16-Year-Old School Students
Volume: 10 Issue: 4
Author(s): Georgia A. Naldrett and Jane L Wood*
Affiliation:
- Centre of Research and Education in Forensic Psychology (CORE-FP), School of Psychology, University of Kent, Canterbury, Kent, CT2 7NP,United Kingdom
Keywords: Gangs, anxiety, depression, paranoia, victim and perpetrator trauma, mental-illness.
Abstract: Background and Goals: The current study investigated the relationship between gang involvement and multiple mental health difficulties; anxiety, depression, paranoia, victim trauma and perpetrator trauma. Additionally, it examined the mediating influence of an individual’s exposure to violence within this relationship.
Method: One hundred adolescents aged 11-16 years old completed two questionnaires and an interview which investigated their friendship groups, exposure to violence and mental well-being. Eighteen participants were identified as current or ex-gang members and the other eighty-two were classified as the nongang comparison group. Results: Findings show that gang members displayed more symptoms of depression and perpetrator trauma compared to non-gang members. The relationship between gang involvement and these mental health difficulties was mediated by exposure to violence. Conclusion: Discussion focuses on the need for researchers, practitioners and policymakers to acknowledge the relationship between gang involvement and mental health difficulties and implement additional strategies to support young people currently or previously involved in gangs.Export Options
About this article
Cite this article as:
Naldrett A. Georgia and Wood L Jane *, Gang Involvement, Mental Health Difficulties and Exposure to Violence in 11-16-Year-Old School Students, Adolescent Psychiatry 2020; 10 (4) . https://dx.doi.org/10.2174/2210676610999201229141153
DOI https://dx.doi.org/10.2174/2210676610999201229141153 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Chemopreventive Role of Boldine Against Hepatocellular Carcinoma via Modulation of Cell Cycle Proteins in Rat Model
Anti-Cancer Agents in Medicinal Chemistry Single Amino Acid Repeats Connect Viruses to Neurodegeneration
Current Drug Discovery Technologies Treatment of the Motor and Non-Motor Symptoms in Parkinson's Disease According to Cluster Symptoms Presentation
Current Drug Targets Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases
Current Neuropharmacology Safflor Protected Rat Cerebral Ischemia-Reperfusion Injury Through Inhibiting the Expression of NF-kB and IL-1β
Neuroscience and Biomedical Engineering (Discontinued) Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS
Current Alzheimer Research The Brain Epinephrine-α1-Adrenoceptor System in Behavioral Activation and Depression
Current Psychiatry Reviews Isolation of Secreted microRNAs (miRNAs) from Cell-conditioned Media
MicroRNA Anti-Cocaine Vaccine Based on Coupling a Cocaine Analog to a Disrupted Adenovirus
CNS & Neurological Disorders - Drug Targets Calculation of Young's Modulus Value by Means of AFM
Recent Patents on Nanotechnology A New Series of 1,3-Dimethylxanthine Based Adenosine A<sub>2A</sub> Receptor Antagonists as a Non-Dopaminergic Treatment of Parkinson’s Disease
Current Drug Discovery Technologies Oxidative Stress and Nitric Oxide in Autism Spectrum Disorder and Other Neuropsychiatric Disorders
CNS & Neurological Disorders - Drug Targets Low Molecular Weight Compounds with Transition Metals as Free Radical Scavengers and Novel Therapeutic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Differentiation Between Osteoporotic and Neoplastic Vertebral Fractures: State of The Art and Future Perspectives
Current Medical Imaging Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews Cerebral Hypoperfusion in Hereditary Coproporphyria (HCP): A Single Photon Emission Computed Tomography (SPECT) Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Methods to Access 2-aminobenzimidazoles of Medicinal Importance
Current Organic Chemistry A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer’s Disease
Current Clinical Pharmacology Visceral Adipose Tissue and Atherosclerosis
Current Vascular Pharmacology Monoclonal Antibodies in Solid Tumours
Current Clinical Pharmacology